Burning Rock Biotech Limited: cashflow_investing
| Value | {"amount": -16752000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | Burning Rock Biotech Limited |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:06:26.759839+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7b0e3878-d4ae-415c-b89f-f1bccf244f0a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-090543Retrieved: 2026-08-19T18:06:26.759839+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001792267/cashflow-investing/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7b0e3878-d4ae-415c-b89f-f1bccf244f0a
History
- supersedes {"unit": "CNY", "value": -109312000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities"} (evidence 0001193125-21-090543)